Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
38.2M
-
Shares change
-
+9.93M
-
Total reported value, excl. options
-
$463M
-
Value change
-
+$120M
-
Put/Call ratio
-
1.63
-
Number of buys
-
93
-
Number of sells
-
-38
-
Price
-
$12.10
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2017
153 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q2 2017.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.2M shares
of 119M outstanding shares and own 32.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.25M shares), FMR LLC (4.63M shares), VANGUARD GROUP INC (3.12M shares), JANUS HENDERSON GROUP PLC (2.68M shares), LANSDOWNE PARTNERS (UK) LLP (2.65M shares), WELLINGTON MANAGEMENT GROUP LLP (2.64M shares), BVF INC/IL (1.99M shares), STATE STREET CORP (1.67M shares), Invesco Ltd. (841K shares), and CITIGROUP INC (800K shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.